During the past decade, Perpetual Succour Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 15 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Perpetual Succour Hospital" #1 sponsor was "Allergan" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Apellis Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Perpetual Succour Hospital" #1 collaborator was "Innogene Kalbiotech Pte. Ltd" with 2 trials as a collaborator, "Laboratorio Elea Phoenix S.A." with 2 trials as a collaborator, "Actoverco" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "CIMAB (Cuba)" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Perpetual Succour Hospital" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Adenocarcinoma" (1 trials) and "Caloric Deficit" (1 trials). Many other conditions were trialed in "Perpetual Succour Hospital" in a lesser frequency.

Most popular intervention types in "Perpetual Succour Hospital" are "Drug" (18 trials), "Biological" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (3 trials), "Pregabalin Dose Level 1" (2 trials), "Pregabalin Dose Level 2" (2 trials) and "Taxane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Perpetual Succour Hospital" are 21 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Perpetual Succour Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Perpetual Succour Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Perpetual Succour Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Perpetual Succour Hospital has several departments that took part in Clinical trials: "Cebu Cancer Institute; Perpetual Succour Hospital" - 4 trials